Arbutus Biopharma Tops Q1 EPS by 5c

  • Investing.com
Arbutus Biopharma Tops Q1 EPS by 5c

Arbutus Biopharma (NASDAQ: ABUS ) reported Q1 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $4.37 million.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles